Kampala, Uganda | THE INDEPENDENT | Activists attending the ongoing International AIDS Conference in Munich Germany have asked the manufacturer of injection Lenacapavir (LEN) which was recently proven to be safe and highly effective at preventing HIV to reduce its prices to make it affordable for all. The drug which is …
Read More »
Kampala, Uganda | THE INDEPENDENT | A new HIV prevention study has found that twice-a-year injections of a new antiviral drug, called lenacapavir, completely protected women from contracting HIV. Findings of the the PURPOSE 1 HIV prevention study among adolescent girls and young women in South Africa and Uganda was released …
Read More »
Researchers to conduct study on its efficacy on women under 25 years Kampala, Uganda | PATRICIA AKANKWATSA | Researchers of the vaccine programme at Uganda Virus Research Institute (UVRI) will start conducting a study among females below 25 years to assess the efficacy of Lenacapavir, an HIV injectable drug. Participants will …
Read More »
Kampala, Uganda | THE INDEPENDENT | Researchers will in December enroll the first participants in a clinical trial in which they are testing the effectiveness of a new HIV drug, Lenacapavir in protecting people against the virus. This study will be conducted in four districts of Mityana, Masaka, Hoima and Kalangala …
Read More »
Kampala, Uganda | THE INDEPENDENT | A new HIV Pre-exposure Prophylaxis (PrEP) study is underway to establish whether a six months-long injectable drug, Lenacapavir (LEN), and oral drug Descovy can protect HIV negative women and girls from acquiring the virus. The two-part study is being done by a team of researchers …
Read More »
The Independent Uganda: You get the Truth we Pay the Price